This inventor holds 3 USPTO granted patents. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1976-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1982
Title: The Innovations of Francis A. Sowinski
Introduction
Francis A. Sowinski is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to his name, Sowinski's work has had a meaningful impact on medical science.
Latest Patents
One of his latest patents is a method for preparing the optically active isomer of a compound that is useful as an antiarrhythmic agent. This method involves the preparation of the optically active isomer [2R-[2.alpha.,3.alpha.,5(R*)]]-2,2'-[[5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-2,3-naphthalenediyl]bis(oxy)]bis-[N,N-dipropylacetamide]. Another significant patent involves novel 1,2,4-benzothiadiazines, which are substituted by an oxo group in the 3-position and can be substituted in the 4-position with various functional groups. These compounds are recognized for their potential as central nervous system depressants and diuretics.
Career Highlights
Francis A. Sowinski has been associated with E.R. Squibb & Sons, Inc., where he has contributed to various innovative projects. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Throughout his career, Sowinski has collaborated with notable colleagues, including B. Richard Vogt and Jerome L. Moniot. These collaborations have fostered a productive environment for innovation and discovery.
Conclusion
Francis A. Sowinski's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of important medical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
